- Home
- Companies
- usa north carolina
- therapy development
Show results for
Refine by
Therapy Development Suppliers Serving Usa North Carolina
109 companies found
based inAltavilla Vicentina (VI), ITALY
FIT Therapy Patch, FIT Therapy Lady and FIT Therapy Posture are trademarks of D.Fenstec s.r.l. FIT Therapy products are Class I Medical Devices, compliant with Directive 93/42/EEC, and can relieve painful symptoms without the use of drugs. CE ...
based inMiami, FLORIDA (USA)
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B, which is derived from culture-expanded medicinal signaling cells (MSCs) ...
based inBochum, GERMANY
Medical products for minimally invasive pain therapy on the spine. Development, experience and competence since 1999. Radimed GmbH develops and sells products for pain therapy on the spine with a focus on methods between conventional therapy and ...
based inSouth San Francisco, CALIFORNIA (USA)
We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Our proprietary technology is designed to harness the power of these important pathogen-fighting immune cells and is uniquely capable of enhancing ...
based inAlameda, CALIFORNIA (USA)
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical ...
based inRostock, GERMANY
The founding of TUR group is an important milestone in our quest toward the establishment of the complete customer support service stipulated in our corporate philosophy. Trends, customer needs and markets are constantly changing. To be successful ...
based inLondon, UNITED KINGDOM
Hemogenyx Pharmaceuticals is developing breakthrough therapies for the treatment of blood diseases. Hemogenyx Pharmaceuticals plc is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx ...
Hemogenyx Pharmaceuticals utilizes postnatal human hemogenic endothelial cells (Hu-PHEC cells), discovered by Hemogenyx Pharmaceuticals’ Co-Founder Dr Vladislav Sandler, to generate cancer-free hematopoietic stem cells (HSC) for use in ...
based inBoston, MASSACHUSETTS (USA)
LayerBio, Inc. is clinical-stage biotechnology company developing innovative therapies to address unmet needs in the field of ophthalmology and other therapeutic areas. LayerBio was founded as a spinoff of Massachusetts Institute of Technology (MIT) ...
based inTeltow, GERMANY
OD-OS is an offshoot of SensoMotoric Instruments GmbH (SMI), located in Teltow, just outside of Berlin, Germany. At the start of 2008, after more than three years of product and technological development at SMI by a team dedicated to Retina ...
based inChatham, NEW JERSEY (USA)
Tonix is a clinical-stage biopharmaceutical company focused on developing novel therapies and vaccines to prevent and treat central nervous system disorders, immunology conditions, infectious diseases, and rare diseases. At Tonix, we are focused on ...
based inCambridge, MASSACHUSETTS (USA)
Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our ...
based inCambridge, MASSACHUSETTS (USA)
We are global leaders in wastewater epidemiology. Our mission is to transform wastewater infrastructure into public health observatories. Founded by a biologist and an architect, our team has exemplified the power of interdisciplinary collaboration ...
based inDanvers, MASSACHUSETTS (USA)
Neutron Therapeutics is a medical equipment company founded in November 2015. We are working to bring Boron Neutron Capture Therapy (BNCT) out of the realm of medical research and transform it into a widely available first-line cancer therapy. We ...
based inPrinceton, NEW JERSEY (USA)
Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” Otsuka researches, develops, manufactures, and markets innovative products, with a focus ...
based inRye Brook, NEW YORK (USA)
Curemark is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of neurological disorders. Our pipeline includes our lead drug candidate, CM-AT, which is in a Phase III clinical trial for Autism, and is ...
based inHavertown, PENNSYLVANIA (USA)
Celebrating 50 YEARS in the platelet testing field, Chrono-log was one of the first companies to manufacture the Platelet Aggregometer based on the Born method of measuring platelet aggregation in Platelet-Rich-Plasma [PRP] samples. Chrono-log has ...
based inManchester, NEW HAMPSHIRE (USA)
ARMI´s mission is to make practical the scalable, consistent, cost-effective manufacturing of tissue engineered medical products and tissue related technologies, to benefit existing industries and grow new ...
based inNewark, CALIFORNIA (USA)
ACD - a Bio-Techne brand, shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and ...
based inSan Diego, CALIFORNIA (USA)
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, ...
based inCambridge, MASSACHUSETTS (USA)
We are a cell therapy company that combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. Vor, the Norse goddess of wisdom, was known as the careful one. ...
The traditional tumor target paradigm aims to treat hematological malignancies such as acute myeloid leukemia (AML) by focusing on the specificity and potency of therapies that kill cancer cells expressing a target. However, this ...
